We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Curing Duchenne Muscular Dystrophy with a New Version of CRISPR

News   Apr 18, 2017 | Original story from UT Southwestern

 
New Version of CRISPR Successfully Repairs Defects in Duchenne Muscular Dystrophy

Image shows heart muscle that is missing the dystrophin molecule. Credit: UT Southwestern

 
 
 

RELATED ARTICLES

Gene Editing Dramatically Improves Inherited Kidney Disease in Mice

News

Gene editing could be used to stop kidney damage in patients who have Joubert syndrome, an inherited kidney disease.

READ MORE

Drug Candidate Could Recover Vocal Abilities Lost to ADNP Syndrome

News

A new Tel Aviv University study finds that the drug candidate CP201, also known as NAP, may improve vocal communication abilities that are underdeveloped in Activity-dependent neuroprotective protein (ADNP) patients.

READ MORE

New Inflammation Inhibitor Discovered

News

A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE